GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt
· Delayed Price · Currency is EGP 67.17
-0.81 (-1.19%)
At close: Apr 28, 2026
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 5.61 billion as of April 28, 2026. Its market cap has increased by 70.40% in one year.
Market Cap
5.61B
Enterprise Value
5.21B
Revenue
3.73B
Ranking
n/a
PE Ratio
26.31
Stock Price
67.17
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 5.61B, an increase of 885.10%. That is a compound annual growth rate of 11.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition